TLR5 agonists are promising anticancer agents because of their safety, as well as their efficacy. Unlike many other TLRs, TLR5 signaling, while immunostimulatory, does not induce certain highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback